LifeStance Therapists & Psychiatrists Suffolk
5131 River Club Drive, Suite 200, Suffolk
4.6(156 Google reviews)
United States
6 listed treatment centers serving Suffolk and the surrounding area.
5131 River Club Drive, Suite 200, Suffolk
4.6(156 Google reviews)
5131 River Club Drive, Suite 200, Suffolk
4.9(21 Google reviews)
5131 River Club Drive, Suite 200, Suffolk
4.3(18 Google reviews)
For people in Suffolk considering SPRAVATO®, the cost depends on insurance benefits, the treatment setting, and the prescribed schedule. Both the medication and the visit for supervised administration and monitoring may be billed. Ask for an explanation of these charges rather than assuming a medication copay covers the entire appointment.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you tried, how long you took them, and how you responded. A treatment center can explain what documentation it needs from your current or previous prescribers. Authorization is not a guarantee that every charge will be covered.
Medicare coverage may fall under Part B or Part D, depending on the setting and plan. Virginia Medicaid coverage also depends on the plan and applicable requirements. Confirm both your benefits and whether the center accepts your coverage before scheduling. Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Ask about current eligibility rules and which expenses a program addresses.
Before starting, ask the center and your insurer:
Clarifying these details early can help you plan without assuming approval or a fixed personal cost.
There is no listed SPRAVATO® treatment center in Suffolk in this directory yet. No nearby listed cities are provided in the available directory information, so we cannot point you to a specific local alternative. This listing gap does not establish that treatment is unavailable. Ask your prescriber or insurer for help identifying a setting, then confirm directly that it is certified through the Spravato REMS program before arranging care.
Treatment takes place only in a REMS-certified healthcare setting. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never sent home with you. Monitoring lasts at least two hours after each dose, so allow more than two hours for the full appointment, including preparation and any additional observation your care team considers necessary.
The typical labeled schedule starts with twice-weekly treatment during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule for your situation; do not assume visits will decrease on a fixed timeline.
Arrange for someone else to take you home after every appointment. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its ride and pickup requirements, and have a backup plan if your usual driver is unavailable.
When planning time off work, account for travel, check-in, monitoring, and the driving restriction afterward. Discuss safety-sensitive job duties with your clinician. Coordinating rides, childcare, and work commitments before the first dose can make repeated visits more manageable.
This directory currently has no listed SPRAVATO® center in Suffolk, and the available information does not identify nearby listed cities. Ask your prescriber or insurer to help locate a treatment setting. Before booking, confirm directly that the location is REMS-certified, is accepting patients, and can evaluate your needs. A statement that a practice offers Spravato is not, by itself, confirmation of certification.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your diagnosis, treatment history, and health risks; meeting an approved indication does not automatically make it appropriate for you.
Coverage depends on your plan and the treatment setting. Prior authorization and records of previous antidepressant trials are common requirements. The medicine and supervised monitoring visit may generate separate charges. Medicare and Virginia Medicaid may cover treatment depending on the plan and setting, but coverage is not assured. Ask your insurer about network status, authorization, and your share of both medication and visit costs before starting.
You use the nasal spray yourself under a healthcare provider’s direct observation in a REMS-certified setting. After each dose, staff monitor you for at least two hours, including checks for sedation, dissociation, breathing problems, and blood pressure increases. The full appointment may take longer. You cannot take the medicine home, and you need someone else to take you home after treatment.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your medical history and medicines with your clinician, and tell staff immediately if you feel unwell during observation.
You must not drive or operate machinery until the next day after a restful sleep, even if you feel ready sooner. Arrange a ride home for every visit and ask about the center’s pickup rules. Plan time away from work for the appointment and discuss any safety-sensitive duties with your clinician. Completing the minimum monitoring period does not mean you are cleared to drive.
Do not wait for a treatment appointment to seek urgent help. In a crisis, call or text 988; call 911 for an immediate emergency. Spravato has not been demonstrated to prevent suicide or reduce suicidal thoughts or behaviors. Although it has an approved use for depressive symptoms in certain adults with acute suicidal ideation or behavior, it does not replace hospitalization when clinically needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.